Immunohistochemical detection of IDH1 mutation, p53, and internexin as prognostic factors of glial tumors
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunohistochemical detection of IDH1 mutation, p53, and internexin as prognostic factors of glial tumors
Authors
Keywords
-
Journal
JOURNAL OF NEURO-ONCOLOGY
Volume 108, Issue 3, Pages 361-373
Publisher
Springer Nature
Online
2012-03-06
DOI
10.1007/s11060-012-0837-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Establishment of a novel monoclonal antibody SMab-1 specific for IDH1-R132S mutation
- (2011) Mika Kato Kaneko et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Detection of IDH1 mutation in human gliomas: comparison of immunohistochemistry and sequencing
- (2011) Shingo Takano et al. Brain Tumor Pathology
- IDH1mutations in grade II astrocytomas are associated with unfavorable progression-free survival and prolonged postrecurrence survival
- (2011) Niklas Thon et al. CANCER
- Alpha-internexin expression predicts outcome in anaplastic oligodendroglial tumors and may positively impact the efficacy of chemotherapy
- (2011) Karima Mokhtari et al. CANCER
- Isocitrate dehydrogenase mutations in diffuse gliomas: clinical and aetiological implications
- (2011) R. Gupta et al. JOURNAL OF CLINICAL PATHOLOGY
- Alpha-internexin expression in gliomas: relationship with histological type and 1p, 19q, 10p and 10q status
- (2011) K. Durand et al. JOURNAL OF CLINICAL PATHOLOGY
- IDH mutation status impact on in vivo hypoxia biomarkers expression: new insights from a clinical, nuclear imaging and immunohistochemical study in 33 glioma patients
- (2011) Philippe Metellus et al. JOURNAL OF NEURO-ONCOLOGY
- Value and Limitations of Immunohistochemistry and Gene Sequencing for Detection of theIDH1-R132HMutation in Diffuse Glioma Biopsy Specimens
- (2011) Matthias Preusser et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers
- (2011) Stephen Yip et al. JOURNAL OF PATHOLOGY
- R132H-mutation of isocitrate dehydrogenase-1 is not sufficient for HIF-1α upregulation in adult glioma
- (2010) Susan C. Williams et al. ACTA NEUROPATHOLOGICA
- Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas
- (2010) Christian Hartmann et al. ACTA NEUROPATHOLOGICA
- Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosis
- (2010) Philippe Metellus et al. ACTA NEUROPATHOLOGICA
- Molecular Classification of Low-Grade Diffuse Gliomas
- (2010) Young-Ho Kim et al. AMERICAN JOURNAL OF PATHOLOGY
- p53 abnormality and tumor invasion in patients with malignant astrocytoma
- (2010) Hiroyuki Momota et al. Brain Tumor Pathology
- IDH1 and IDH2 Mutations Are Prognostic but not Predictive for Outcome in Anaplastic Oligodendroglial Tumors: A Report of the European Organization for Research and Treatment of Cancer Brain Tumor Group
- (2010) M. J. van den Bent et al. CLINICAL CANCER RESEARCH
- Diagnostic and prognostic value of alpha internexin expression in a series of 409 gliomas
- (2010) François Ducray et al. EUROPEAN JOURNAL OF CANCER
- MGMT activity, promoter methylation and immunohistochemistry of pretreatment and recurrent malignant gliomas: a comparative study on astrocytoma and glioblastoma
- (2010) Markus Christmann et al. INTERNATIONAL JOURNAL OF CANCER
- O 6-Methylguanine DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression is correlated with progression-free survival in patients with glioblastoma
- (2010) Yukihiko Sonoda et al. International Journal of Clinical Oncology
- Isocitrate dehydrogenase-1 mutations: a fundamentally new understanding of diffuse glioma?
- (2010) Nanne K Kloosterhof et al. LANCET ONCOLOGY
- IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas
- (2010) C. Houillier et al. NEUROLOGY
- Monoclonal antibody specific for IDH1 R132H mutation
- (2009) David Capper et al. ACTA NEUROPATHOLOGICA
- IDH1 Mutations Are Early Events in the Development of Astrocytomas and Oligodendrogliomas
- (2009) Takuya Watanabe et al. AMERICAN JOURNAL OF PATHOLOGY
- A monoclonal antibody IMab-1 specifically recognizes IDH1R132H, the most common glioma-derived mutation
- (2009) Yukinari Kato et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Characterization of R132H Mutation-specific IDH1 Antibody Binding in Brain Tumors
- (2009) David Capper et al. BRAIN PATHOLOGY
- Analysis ofIDH1andIDH2mutations in Japanese glioma patients
- (2009) Yukihiko Sonoda et al. CANCER SCIENCE
- Genetic alterations and signaling pathways in the evolution of gliomas
- (2009) Hiroko Ohgaki et al. CANCER SCIENCE
- Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomas
- (2009) Marc Sanson et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
- (2009) Lenny Dang et al. NATURE
- -Internexin expression identifies 1p19q codeleted gliomas
- (2009) F. Ducray et al. NEUROLOGY
- IDH1 mutations in low-grade astrocytomas predict survival but not response to temozolomide
- (2009) H. J. Dubbink et al. NEUROLOGY
- THE CORRELATION AND PROGNOSTIC SIGNIFICANCE OF MGMT PROMOTER METHYLATION AND MGMT PROTEIN IN GLIOBLASTOMAS
- (2009) Van Thang Cao et al. NEUROSURGERY
- IDH1andIDH2Mutations in Gliomas
- (2009) Hai Yan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1
- (2009) S. Zhao et al. SCIENCE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now